Why Are Some Studies of Cardiovascular Markers Unreliable? The Role of Measurement Variability and What an Aspiring Clinician Scientist Can Do Before It Is Too Late

Progress in Cardiovascular Diseases - Tập 55 - Trang 14-24 - 2012
Matthew Shun-Shin1, Darrel P. Francis1
1International Centre for Circulatory Health, National Heart and Lung institute, Imperial College, London, United Kingdom

Tài liệu tham khảo

Vasan, 2006, Biomarkers of cardiovascular disease: molecular basis and practical considerations, Circulation, 113, 2335, 10.1161/CIRCULATIONAHA.104.482570 Tzoulaki, 2011, Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study, BMJ, 343, d6829, 10.1136/bmj.d6829 Ioannidis, 2005, Contradicted and initially stronger effects in highly cited clinical research, JAMA, 294, 218, 10.1001/jama.294.2.218 Rutjes, 2006, Evidence of bias and variation in diagnostic accuracy studies, CMAJ, 174, 469, 10.1503/cmaj.050090 Ransohoff, 2005, Bias as a threat to the validity of cancer molecular-marker research, Nat Rev Cancer, 5, 142, 10.1038/nrc1550 Nijjer, 2012, Limits of plausibility for predictors of response to cardiac resynchronisation therapy: systematic review and design steps for reliable research, JACC Cardiovasc Imaging Ioannidis, 2011, Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses, JAMA, 305, 2200, 10.1001/jama.2011.713 Hansson, 1999, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial, Lancet, 353, 611, 10.1016/S0140-6736(98)05012-0 Peto, 1999, Failure of randomisation by “sealed” envelope, Lancet, 354, 73, 10.1016/S0140-6736(05)75340-X Broad, 1983 Sackett, 1979, Bias in analytic research, J Chronic Dis, 32, 51, 10.1016/0021-9681(79)90012-2 Ross, 1968, Aortic stenosis, Circulation, 38, 61 Bland, 1994, Regression towards the mean, BMJ, 308, 1499, 10.1136/bmj.308.6942.1499 Herpin, 1994, Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass. Quantification and clinical implications, Am J Hypertens, 7, 824, 10.1093/ajh/7.9.824 Strauer, 2010, The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study, Eur J Heart Fail, 12, 721, 10.1093/eurjhf/hfq095 Cole, 2011, Comparable or STAR-heartlingly different left ventricular ejection fraction at baseline?, Eur J Heart Fail, 13, 234, 10.1093/eurjhf/hfq214 Day, 1968, Auscultation of foetal heart rate: an assessment of its error and significance, Br Med J, 4, 422, 10.1136/bmj.4.5628.422 Francis, 2012, How easily can omission of patients, or selection amongst poorly-reproducible measurements, create artificial correlations? Methods for detection and implications for observational research design in cardiology, Int J Cardiol, 1 2008 National Institute for Health and Clinical Excellence 2011 Hypertension, 2011 Bruins, 2004, High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure, Clin Chem, 50, 2052, 10.1373/clinchem.2004.038752 Francis, 1999, How high can a correlation coefficient be? Effects of limited reproducibility of common cardiological measures, Int J Cardiol, 69, 185, 10.1016/S0167-5273(99)00028-5 Elm von, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, 335, 806, 10.1136/bmj.39335.541782.AD Tavris, 2008 Ahmad, 2012, Novel biomarkers in chronic heart failure, Nat Rev Cardiol, 347, 10.1038/nrcardio.2012.37 Kattan, 2004, Evaluating a new marker's predictive contribution, Clin Cancer Res, 10, 822, 10.1158/1078-0432.CCR-03-0061 Greenland, 2005, When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk, Arch Intern Med, 165, 2454, 10.1001/archinte.165.21.2454 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Ip, 2009, Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes, Ann Intern Med, 150, 474, 10.7326/0003-4819-150-7-200904070-00007